NCT06434558
Imaging Predictors of Cryolysis Efficacy for Treatment of Obstructive Sleep Apnea
Enrolling by Invitation
Not specifiedAll AgesObservationalUniversity of PennsylvaniaInvestigator-initiated
~10 participants
Updated 2025-10-31 on ClinicalTrials.gov
What's tested:Cryosa Procedure
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change from Baseline in Oropharyngeal Fat at 6 Months
Measured over Baseline and 6 months
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Study leadership
- Raj Dedhia, MD · PRINCIPAL_INVESTIGATOR · University of Pennsylvania
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Enrolled in the ARCTIC-3 clinical trial at the University of Pennsylvania\*
Provision of signed and dated informed consent form for ICE-OSA
Exclusion
MRI contraindications (claustrophobia, ferromagnetic implants/foreign bodies, etc.)
Patient is pregnant or becomes pregnant during their enrollment
What this trial measures
- Change from Baseline in Oropharyngeal Fat at 6 MonthsBaseline and 6 months
Quantity of oropharyngeal fat will be measured with magnetic resonance imaging (MRI) before the Cryosa Procedure and 6 months after the Cryosa Procedure in all subject participants.
- Change in Baseline Apnea Hypopnea Index at 6 MonthsBaseline and 6 Months
All participants in this study, who are also enrolled in the ARCTIC-3 study, are undergoing a polysomnogram as part of the ARCTIC-3 study at baseline and at 6 months. AHI is measured during these sleep studies in every patient at both timepoints.